Connect With a Global Community of Precision Medicine Leaders
As the only event dedicated exclusively to precision medicine in inflammatory bowel disease, this summit brings together senior biopharma executives actively driving innovation. It’s the ideal platform to showcase your solutions, uncover unmet needs, and form high-impact collaborations that accelerate therapeutic development.
Partners have a unique opportunity to address the key challenges facing the IBD field today, from disease heterogeneity and suboptimal treatment response to the complexity of biomarker-driven patient stratification. By presenting cutting-edge diagnostics, AI-driven platforms, innovative preclinical models, and combination therapy strategies, partners can help shape solutions that improve patient outcomes and drive the next wave of precision medicine breakthroughs.
What To Expect:
Raise Your Brand Visibility
Position your organization in front of decision-makers shaping the IBD pipeline, including heads of translational research, clinical development, and diagnostics.
Forge Strategic Collaborations
Connect with influencers and innovators exploring AI-driven biomarker discovery, combination therapy strategies, and next-generation preclinical models.
Showcase Innovation
Present your cutting-edge technologies and platforms to an audience actively seeking tools to accelerate precision medicine in IBD.
Influence the Field
Contribute to discussions on regulatory, translational, and clinical challenges, and shape the future of targeted therapies for Crohn’s and Ulcerative Colitis.
Key Interest Areas
Our attendees from top Biotech and Pharma organisations are looking for service and solution providers in the following areas:
Preclinical Model Providers
Diagnostic tools
AI / Computational Biology Providers
Omics Providers
Preclinical CROs
Organoid Providers
Attending Companies Include